Talkspace Past Earnings Performance
Past criteria checks 0/6
Talkspace has been growing earnings at an average annual rate of 2.2%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 15.4% per year.
Key information
2.2%
Earnings growth rate
61.7%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 15.4% |
| Return on equity | -6.7% |
| Net Margin | -4.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
US$3.50: That's What Analysts Think Talkspace, Inc. (NASDAQ:TALK) Is Worth After Its Latest Results
Aug 09
Investors Interested In Talkspace, Inc.'s (NASDAQ:TALK) Revenues
Jun 13Talkspace (NASDAQ:TALK) Is In A Strong Position To Grow Its Business
Mar 26Talkspace, Inc. (NASDAQ:TALK) Looks Just Right With A 29% Price Jump
Feb 27Talkspace: Opportunities In Online Mental Health And AI, But Faces Competition
Jan 19Market Participants Recognise Talkspace, Inc.'s (NASDAQ:TALK) Revenues Pushing Shares 27% Higher
Dec 19Are Investors Undervaluing Talkspace, Inc. (NASDAQ:TALK) By 49%?
Oct 27Here's Why We're Not Too Worried About Talkspace's (NASDAQ:TALK) Cash Burn Situation
Jul 13Here's Why We're Watching Talkspace's (NASDAQ:TALK) Cash Burn Situation
Mar 13Talkspace: The Weakness Continues
Sep 30Talkspace: Deep Value Opportunity Primed For A Takeout
Jun 18Talkspace: How Does This Get Fixed?
Mar 01Talkspace, Inc. (NASDAQ:TALK) Just Reported And Analysts Have Been Cutting Their Estimates
Feb 25A First Take On Talkspace
Dec 31Talkspace: The Market Wants To Push This To Zero
Dec 12Revenue & Expenses Breakdown
How Talkspace makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 173 | -8 | 75 | 14 |
| 31 Mar 24 | 162 | -12 | 73 | 16 |
| 31 Dec 23 | 150 | -19 | 74 | 18 |
| 30 Sep 23 | 138 | -36 | 82 | 18 |
| 30 Jun 23 | 129 | -50 | 89 | 21 |
| 31 Mar 23 | 123 | -68 | 99 | 22 |
| 31 Dec 22 | 120 | -80 | 109 | 22 |
| 30 Sep 22 | 118 | -82 | 120 | 21 |
| 30 Jun 22 | 116 | -63 | 128 | 19 |
| 31 Mar 22 | 117 | -70 | 140 | 18 |
| 31 Dec 21 | 114 | -63 | 135 | 16 |
| 30 Sep 21 | 110 | -53 | 122 | 14 |
| 30 Jun 21 | 105 | -57 | 103 | 12 |
| 31 Mar 21 | 92 | -27 | 73 | 10 |
| 31 Dec 20 | 76 | -22 | 58 | 10 |
| 30 Sep 20 | 62 | -20 | 45 | 11 |
| 31 Dec 19 | 38 | -29 | 33 | 12 |
| 31 Dec 18 | 29 | -20 | 23 | 8 |
Quality Earnings: TALK is currently unprofitable.
Growing Profit Margin: TALK is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TALK is unprofitable, but has reduced losses over the past 5 years at a rate of 2.2% per year.
Accelerating Growth: Unable to compare TALK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TALK is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6%).
Return on Equity
High ROE: TALK has a negative Return on Equity (-6.72%), as it is currently unprofitable.